Table 1.
VITAH trial inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| • Age ≥ 18 years |
• Any major cardiovascular event within the last 6 months prior to enrolment (this includes, but is not limited to, new onset arrhythmia, hospitalization for a cardiovascular complication) |
| • Thrice weekly hemodialysis outpatient within the Southern Alberta Renal Program |
|
| • Physician consent to participate |
• Refusal to cease vitamin D therapy for four (4) weeks prior to initiation of the study |
| • Ability and agreement to cease any prior vitamin D medication for four (4) weeks prior to initiation of the study |
• Palliative status or metastatic malignancy |
| • Ability to comprehend study protocol and provide oral and written consent in English (native language or translated) | • Known or anticipated upcoming change in dialysis modality including transfer to peritoneal dialysis, kidney transplant, or change in current hemodialysis schedule/duration |